BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16983000)

  • 1. Lymphoma risk in psoriasis: results of the PUVA follow-up study.
    Stern RS
    Arch Dermatol; 2006 Sep; 142(9):1132-5. PubMed ID: 16983000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
    Stern RS; Nichols KT; Väkevä LH
    N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study.
    Malanos D; Stern RS
    J Am Acad Dermatol; 2007 Aug; 57(2):231-7. PubMed ID: 17532094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of melanoma in association with long-term exposure to PUVA.
    Stern RS;
    J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical severity of psoriasis in last 20 years of PUVA study.
    Nijsten T; Looman CW; Stern RS
    Arch Dermatol; 2007 Sep; 143(9):1113-21. PubMed ID: 17875871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS
    Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy.
    Fortune DG; Richards HL; Kirby B; McElhone K; Markham T; Rogers S; Main CJ; Griffiths CE
    Arch Dermatol; 2003 Jun; 139(6):752-6. PubMed ID: 12810506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS;
    J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis.
    Stern RS; Lange R
    Arch Dermatol; 1991 Mar; 127(3):347-50. PubMed ID: 1998364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study.
    Stern RS
    N Engl J Med; 1990 Apr; 322(16):1093-7. PubMed ID: 2320078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.
    Wolfe F; Michaud K
    Arthritis Rheum; 2007 May; 56(5):1433-9. PubMed ID: 17469100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial.
    Schiener R; Brockow T; Franke A; Salzer B; Peter RU; Resch KL
    Arch Dermatol; 2007 May; 143(5):586-96. PubMed ID: 17519218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
    Henseler T; Christophers E
    Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PUVA treatment and skin cancer: A follow-up study.
    Lassus A; Reunala T; Idänpää-Heikkilä J; Juvakoski T; Salo O
    Acta Derm Venereol; 1981; 61(2):141-5. PubMed ID: 6165190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey.
    Nijsten T; Margolis DJ; Feldman SR; Rolstad T; Stern RS
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):434-44. PubMed ID: 15761421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
    Marcil I; Stern RS
    Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
    Harnes DK; Thune P
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):200-1. PubMed ID: 8430401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
    Vussuki E; Ziv M; Rosenman D; David M
    Harefuah; 2006 Jul; 145(7):483-5, 552, 551. PubMed ID: 16900734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use.
    Behnam SM; Behnam SE; Koo JY
    J Drugs Dermatol; 2005; 4(2):189-94. PubMed ID: 15776776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.